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Challenges of one-year longitudinal follow-
up of a prospective, observational cohort
study using an anonymised database:




Background: Trainee research collaboratives (TRCs) have pioneered high quality, prospective ‘snap-shot’ surgical
cohort studies in the UK. Outcomes After Kidney injury in Surgery (OAKS) was the first TRC cohort study to attempt
to collect one-year follow-up data. The aims of this study were to evaluate one-year follow-up and data completion
rates, and to identify factors associated with improved follow-up rates.
Methods: In this multicentre study, patients undergoing major gastrointestinal surgery were prospectively
identified and followed up at one-year following surgery for six clinical outcomes. The primary outcome for this
report was the follow-up rate for mortality at 1 year. The secondary outcome was the data completeness rate in
those patients who were followed-up. An electronic survey was disseminated to investigators to identify strategies
associated with improved follow-up.
Results: Of the 173 centres that collected baseline data, 126 centres registered to participate in one-year follow-up.
Overall 62.3% (3482/5585) of patients were followed-up at 1 year; in centres registered to collect one-year
outcomes, the follow-up rate was 82.6% (3482/4213). There were no differences in sex, comorbidity, operative
urgency, or 7-day postoperative AKI rate between patients who were lost to follow-up and those who were
successfully followed-up. In centres registered to collect one-year follow-up outcomes, overall data completeness
was 83.1%, with 57.9% (73/126) of centres having ≥95% data completeness. Factors associated with increased
likelihood of achieving ≥95% data completeness were total number of patients to be followed-up (77.4% in centres
with < 15 patients, 59.0% with 15–29 patients, 51.4% with 30–59 patients, and 36.8% with > 60 patients, p = 0.030),
and central versus local storage of patient identifiers (72.5% vs 48.0%, respectively, p = 0.006).
Conclusions: TRC methodology can be used to follow-up patients identified in prospective cohort studies at one-
year. Follow-up rates are maximized by central storage of patient identifiers.
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Background
Trainee research collaboratives (TRCs) have pioneered
methods of rapidly delivering high quality, prospective,
cross-sectional ‘snapshots’ of surgical practice and out-
comes [1, 2]. TRC studies are led by frontline clinicians
and students, without the need for significant additional
infrastructural resources or funding. They capture data
over short time periods across multiple centres, collating
large datasets [3–5] that can be used to generate hypoth-
eses for future randomised trials and identify targets for
national quality improvement [6–10].
TRC studies are delivered by student and postgraduate
trainees who rotate between hospitals at least once every
12 months, which would create discontinuity within local
teams if studies were run over protracted periods of
time. Consequently, most surgical TRC studies follow
patients up to the point of discharge or to postoperative
day 30; no published observational studies from TRCs
have undertaken outcome assessment beyond 6 months
[6–10]. In planning longer term follow-up, a particular
challenge is ensuring safe local storage of patient identi-
fiers so that patients can be followed-up at one-year
even if the original study collaborators at that site have
rotated to continue their training at another centre.
Outcomes After Kidney injury in Surgery (OAKS) was
the first TRC cohort study to attempt to collect to one-
year follow-up data. The aim of this study was to evaluate
one-year follow-up and data completion rates, and to
identify factors associated with improved follow-up rates.
Methods
Student Audit and Research in Surgery (STARSurg)
Student Audit and Research in Surgery (STARSurg) is
the UK’s national medical student research collaborative.
It is coordinated by a team of medical students and post-
graduate trainees. The collaborative model and the edu-
cational benefits to participating students have been
described previously [11, 12]. STARSurg studies are de-
livered by ‘mini-teams’ at each centre consisting of con-
sultant surgeons, junior doctors and medical students.
Outcomes After Kidney injury in Surgery
Outcomes After Kidney injury in Surgery (OAKS) [13] is a
multicentre study which prospectively identified patients
in the UK and Republic of Ireland undergoing major
gastrointestinal or liver resection, or reversal of ileostomy
or colostomy from 23 September 2015 to 18 November
2015. In the United Kingdom, the South-East Scotland Re-
search Ethics Service (reference: NR/1506AB4) confirmed
that ethical review was not required, as this observational
study only collected routine, non- patient identifiable data.
Individual participating UK centres were responsible for
registering the study locally as either clinical audit or ser-
vice evaluation. In the Republic of Ireland, participating
centres were responsible for securing research ethics ap-
proval locally, as required by institutional regulations. The
30-day outcomes from the OAKS study have been re-
ported previously [14, 15].
Data was collected on the Research Electronic Data
Capture (REDCap) system, an online platform for secure
web-based data collection. The REDCap platform was
developed in 2004 at Vanderbilt University, which is a
secure data collection tool meeting the Health Insurance
Portability and Accountability Act (HIPAA) compliance
standards. Patients’ hospital or NHS identification num-
bers and linked study-specific identification numbers
were stored in accordance with local Caldicott Guardian
approvals; either centrally on the REDCap system or
within an encrypted spreadsheet held securely on the
local hospital computer network by a member of the
data collection team (a local investigator, supervising
consultant, or audit officer).
In the period November 2016 to May 2017 the STAR
Surg network collected one-year outcomes for the pa-
tients identified in the initial prospective patient enrol-
ment phase of OAKS. Patients were excluded from one-
year follow-up if they had died within 30 days of index
surgery, as there would be no additional data to collect
from these patients since the 30-day follow-up that had
already been completed previously. At centres that had
participated in initial OAKS data collection, new mini-
teams were recruited to complete one-year follow-up.
The clinical endpoints collected at one-year were (1)
mortality at 1-year, (2) myocardial infarction or cerebro-
vascular accident at 1-year, (3) total combined hospital
length of stay up to 1-year postoperatively, (4) the most
recent available serum creatinine value up to 1-year, (5)
nephrology review at 1-year, and (6) dialysis at 1-year.
These clinical endpoints based on a review of the litera-
ture on postoperative AKI [16–19]. In this observational
study, clinic follow-up visits and blood tests were ar-
ranged by clinical teams according to their normal prac-
tice. No additional follow-up visits or blood tests were
arranged for this study. Follow-up was considered to
have been achieved if patients’ records had been success-
fully reviewed, even if no creatinine tests had been com-
pleted by the clinical team during the follow-up period.
Centres were considered to have registered for collec-
tion of one-year follow-up if a data collection mini-team
was established at the site, institutional approval was
granted for collected of follow-up data, and at least one
patient was followed-up at the site.
Outcome measures
The primary outcome for this report was the mortality
follow-up rate for mortality. This was the proportion of
patients for whom the primary endpoint (mortality) was
followed-up at 1-year. The secondary outcome was the
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data completeness rate in centres that registered to col-
lect one-year follow-up. The data completion rate was
the proportion of patients with complete data for all six
clinical endpoints.
Investigator feedback survey
Following locking of the OAKS database, an electronic
survey was disseminated to all investigators who had
participated in one-year follow-up (Additional file 1:
Table S1). This assessed investigators’ experience of
one-year follow-up data collection. 5-point Likert scales
were used to assess investigators’ experience of the fol-
lowing (from 1 = very difficult, to 5 = very easy): identify-
ing a supervising consultant; registering the audit;
linking patient hospital identifier to the study-specific
identifier; collecting data using local hospital computer
systems, or paper records. For analysis, scores of 4 to 5
out of 5 were categorised as “Positive”, and scores of 1
to 3 out of 5 were categorised as “Negative” responses to
create a dichotomous variable.
Statistical analysis
The baseline characteristics of patients lost to follow-up
were compared to those patients who were successfully
followed-up. Continuous variables were expressed as
mean with standard deviation, or median with interquar-
tile range. Continuous variables were analysed using t-
test or Mann-Whitney test, where appropriate. Categor-
ical variables were expressed as percentages and ana-
lysed using Chi-squared test, or with Fisher’s exact
modification if expected cell counts were less than five.
For all analyses, a p-value of < 0.05 was considered as
statistically significant. Data analysis was undertaken
using R Foundation Statistical Software (R 3.2.1, R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Centre registration
Of 173 centres that had collected baseline data in the
initial phase of OAKS, 126 centres registered to partici-
pate in one-year follow-up. Of the 47 centres that did
not register, 35 were unable to obtain patient ID link
sheets, and 12 were not granted audit and/or Caldicott
Guardian approval prior to the data collection deadline
(Fig. 1). Centres in Scotland, Ireland, and England all
achieved similar levels of registration to participate in
one-year follow-up (88.9% vs 78.6% vs 72.5% respect-
ively, Table 2), however there were significantly fewer
Fig. 1 Flowchart of 1-year follow-up in the OAKS study
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centres in Wales (40.0%). Centres at which a junior doctor
was engaged in the process were more likely to register to
enter data (80.6% vs 46.2%, p < 0.001). Centres which had
stored patient hospital identifiers on the central REDCap
system during the initial data collection phase had a sig-
nificantly higher participation rate in one-year follow-up
(83.6% vs 67.0%, p = 0.019). However, prior centre partici-
pation in STARSurg projects preceding OAKS did not
affect the likelihood of centres registering to collect one-
year follow-up (74.8% vs 61.5%, p = 0.160).
Follow-up rates
The initial data collection phase of OAKS captured
5745 patients, of whom 5585 remained alive at 30-
days following their index procedure (Fig. 1) and eli-
gible for one-year follow-up. Overall 62.3% (3482/
5585) of patients were followed-up at 1 year. Of the
2103 patients lost to follow-up, 65.2% (1372) were
from the 47 centres that did not register to partici-
pate in one-year follow-up. In registered centres, the
follow-up rate was 82.6% (3482/4213).
Characteristics of patients followed-up at one-year
There were no significant differences in age, American So-
ciety of Anaesthesiologists (ASA) grade, Revised Cardiac
Risk Index (RCRI), urgency of surgery and contamination
between patients with and without follow-up at one-year
(Table 1). However, patients who were followed-up had sig-
nificantly higher rates of open surgery compared to patients
that were not followed-up (61.5% vs 52.0%, p < 0.001).
There were no significant difference in rates of AKI (12.7%
vs 10.7%, p = 0.060) between patients with and without
one-year follow-up.
Data completeness
Centre characteristics associated with ≥95% complete-
ness are presented in Table 2. In centres registered to
collect 1-year follow-up outcomes, overall data com-
pleteness was 83.1%. Of the 126 of centres that partici-
pated, 57.9% (n = 73) had ≥95% data completeness.
Scotland had significantly more centres with ≥95% data
completeness (100.0%) compared to England, Ireland,
and Wales (55.8% vs 36.4% vs 0%, p < 0.001). The more
patients a centre had to follow-up, the less likely it was
to achieve ≥95% data completeness (< 15: 77.4% vs 15–
29: 59.0% vs 30–59: 51.4 vs > 60: 36.8%). Centres storing
patient identifiers on the central REDCap system had
significantly higher rates of ≥95% data completeness
than those storing identifiers locally (72.5% vs 48.0%, re-
spectively, p < 0.001).
Investigator feedback survey
Survey responses were received from 285 students and
junior doctors, a 78% (285/365) response rate. At least
one response was received from 86% (148/173) of centres
that participated in initial data collection in 2015. Of cen-
tres that returned the survey, 59 (40.0%) had 100% data
completion of one-year follow-up, 72 (48.6%) had ≥95%
data completion and 23 (15.5%) did not register to submit
one-year follow-up data. Table 3 summarises respondent






Age (years) Mean (SD) 62.8 (15.9) 62.6 (16) 0.689
Gender Female 1561 (44.8) 967 (46.0) 0.417
Male 1920 (55.2) 1137 (54.0)
ASA Grade ASA I-II 2176 (67.0) 1312 (68.5) 0.279
ASA III-V 1071 (33.0) 604 (31.5)
Operative urgency Elective 2752 (79.1) 1687 (80.2) 0.314
Emergency 729 (20.9) 417 (19.8)
RCRI score < 3 3328 (95.7) 2014 (96.0) 0.491
≥3 151 (4.3) 83 (4.0)
Operative approach Laparoscopic 1339 (38.5) 1006 (48.0) < 0.001
Open/ laparoscopic converted to open 2136 (61.5) 1090 (52.0)
Operative contamination Clean-contaminated 3234 (93.2) 1928 (91.9) 0.065
Contaminated 235 (6.8) 170 (8.1)
AKI within 7 days of index surgery No AKI 2979 (85.6) 1837 (87.3) 0.060
AKI 443 (12.7) 225 (10.7)
Missing 59 (1.7) 42 (2.0)
AKI Acute Kidney Injury, ASA American Society of Anaesthesiologists, RCRI Revised Cardiac Risk Index
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characteristics and experience of OAKS-2 by data com-
pleteness. Only collaborators with positive experience of
linking patient ID were more likely to achieve > 95% data
completeness (71.6% vs 37.6%, p < 0.001). There was no
association between perceived difficulty with registering
audit, data collection, and identifying a supervising con-
sultant, and > 95% data completeness. Following this
study, a summary of recommendations for future multi-
centre collaborative studies with longitudinal follow-up
were developed and presented in Table 4.
Discussion
OAKS was the first TRC prospective cohort study to at-
tempt to complete longitudinal one-year follow-up. This
report demonstrates that most centres were able to col-
lect one-year follow-up data with high levels of data
Table 2 OAKS centre characteristics, centre activity and data completeness at one-year postoperatively
Centre active in OAKS Centre ≥95% completeness in OAKS
Active (n = 126) Inactive (n = 47) p-value Yes (n = 73) No (n = 53) p-value
UK Countries England 95 (72.5) 36 (27.5) 0.045 53 (55.8) 42 (44.2) < 0.001
Ireland 11 (78.6) 3 (21.4) 4 (36.4) 7 (63.6)
Scotland 16 (88.9) 2 (11.1) 16 (100.0) 0 (0.0)
Wales 4 (40.0) 6 (60.0) 0 (0.0) 4 (100.0)
Total number of patients to be followed up < 15 patients 31 (70.5) 13 (29.5) 0.491 24 (77.4) 7 (22.6) 0.030
15–29 patients 39 (72.2) 15 (27.8) 23 (59.0) 16 (41.0)
30–59 patients 37 (69.8) 16 (30.2) 19 (51.4) 18 (48.6)
> 60 patients 19 (86.4) 3 (13.6) 7 (36.8) 12 (63.2)
Percentage of patients with complete follow-up Mean (SD) – – – 28.3 (21.6) 27.9 (21.9) 0.877
Junior doctor present in OAKS mini-teama Yes 108 (80.6) 26 (19.4) < 0.001 63 (58.3) 45 (41.7) 0.825
No 18 (46.2) 21 (53.8) 10 (55.6) 8 (44.4)
Central storage of patient hospital identifiers Yes 51 (83.6) 10 (16.4) 0.019 37 (72.5) 14 (27.5) 0.006
No 75 (67.0) 37 (33.0) 36 (48.0) 39 (52.0)
Survey respondents Yes 125 (84.5) 23 (15.5) < 0.001 72 (57.6) 53 (42.4) 0.392
No 1 (4.0) 24 (96.0) 1 (100.0) 0 (0.0)
aJunior doctors are present in each mini-team over a data collection period
Table 3 OAKS collaborator survey responses, centre activity and data completeness at one-year postoperatively
Respondent at a centre with ≥95% completeness
Yes (n = 141) No (n = 111) p-value
Stage of Training Junior Doctor 47 (56.6) 36 (43.4) 0.929
Later Year Student 52 (56.5) 40 (43.5)
Early Year Student 41 (53.9) 35 (46.1)
Previous participation in initial phase of OAKS data collection Yes 66 (56.4) 51 (43.6) 0.850
No 74 (55.2) 60 (44.8)
Prior experience with audit Yes 65 (60.2) 43 (39.8) 0.222
No 75 (52.4) 68 (47.6)
Rating of experience identifying consultant Positive (4–5) 91 (58.7) 64 (41.3) 0.235
Not Positive (< 4) 49 (51.0) 47 (49.0)
Rating of experience registering audit a Positive (4–5) 67 (56.8) 51 (43.2) 0.763
Not Positive (< 4) 73 (54.9) 60 (45.1)
Rating of experience linking Patient ID a Positive (4–5) 96 (71.6) 38 (28.4) < 0.001
Not Positive (< 4) 44 (37.6) 73 (62.4)
Rating of experience collecting data a Positive (4–5) 106 (59.2) 73 (40.8) 0.104
Not Positive (< 4) 34 (47.9) 37 (52.1)
aRated on a self-reported Likert scale between 1 (very difficult) and 5 (very easy)
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completeness. Although the overall follow-up rate was
only 62%, there was no evidence of systematic bias in pa-
tients being followed-up. Factors associated with in-
creased likelihood of achieving > 95% data completeness
were lower numbers of patients to be followed-up, and
central storage of patient hospital identifiers. As TRCs
have now been set up across Europe [20, 21], validating
this methodology will have broad international benefits.
Most studies that complete longitudinal follow-up of pro-
spectively identified patients [22] require patient consent,
ethical approval, and significant research infrastructural
funding. Even in well resourced, funded trials loss to follow-
up of up to 15% is expected and built in to sample size cal-
culations [23]. In the UK, National Research Ethics Service
regulations permitted collection of one-year outcomes to be
completed as clinical audit, without the need for research
ethics approval. Without ethical approval it was not possible
to collect identifiable data centrally. This report demon-
strates that satisfactory follow-up is achievable within this
regulatory framework, and without dedicated funding.
The most commonly reported barrier to achieving one-
year follow-up was inability to identify linked patient re-
cords. Methods for maintaining linkage between hospital
identifiers and study-specific identifiers were either holding
hospital identifiers directly on the REDCap system or hold-
ing a cross-reference of hospital and study-specific identi-
fiers on hospital computer systems by audit offices or
consultants. Collaborating investigators found it easier to
complete data collection when approved hospital identifiers
were stored on the REDCap system. In Scotland, where na-
tional approval was gained for Community Health Index
(CHI) identifiers to be stored on REDCap, data completion
rates were higher. Therefore, future studies should seek
local or national Caldicott guardian approval to store ap-
proved hospital identifiers on REDCap.
Loss to follow-up presents a major risk to the internal
validity of a study as it leaves a specific population where
outcomes remain unassessed, which may differ between
groups. In the OAKS study, there were no significant dif-
ferences in the patient-level demographics, operative indi-
cations or ASA grades between the group that underwent
one-year follow-up and those that did not. The AKI and
mortality rates at 30-days postoperative follow-up also
were not significantly different between the groups that
did and did not achieve one-year follow-up data.
A significant limitation to the method of follow-up in this
study was its restriction to the hospital where the index sur-
gery was performed. A small number of patients may choose
to move their care to another centre, and some patients
may be readmitted to a different hospital. Consequently,
when patients were followed-up at the index hospital, there
may have been no record of readmissions, treatments, and
blood tests that took place at other hospitals. In addition,
since no specific clinic visits were arranged for this study, if
clinical teams did not arrange any postoperative clinic visits,
or patients did not attend arranged visits, it is possible that
the hospital records that were reviewed as source data for
this study may not have been fully accurate.
The evaluation of this study’s methodology was limited
by the broadness of the barriers explored in the investi-
gator survey. A qualitative approach with detailed inter-
views with investigators may have been more likely to
identify specific difficulties that precluded follow-up
from being completed. Incorporating such a qualitative
component to future studies may improve follow-up by
identifying more solutions [24].
Conclusion
The OAKS study has demonstrated that prospective
TRC cohort studies can successfully complete one-year
longitudinal follow-up, with acceptable data complete-
ness rates. Future studies may maximise follow-up rates
by optimising procedures for storage of patient identi-
fiers, embedding collaborators with previous experience
of TRC studies within data collection team, and tracking
regional variation in performance throughout the study.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12874-019-0857-y.
Additional file 1: Table S1. OAKS collaborator survey responses, centre
activity and data completeness at one-year postoperatively.
Table 4 Summary of recommendations for future multi-centre
collaborative studies with longitudinal follow-up
Number Recommendation to improve completeness of
longitudinal follow-up
1. Study Design Recommendations
1.1 Linked patient identifiers should be kept in a central
repository (for example a REDCap system) if Caldicott
Guardian approval is given to minimise loss to follow-up
2. Study Delivery Recommendations
2.1 Included at least one team member with previous
experience in trainee research collaborative projects
in each data collection team, where possible.
2.2 Having junior doctors paired to students in data collection
teams improve centre participation and data completeness
rates. Where this is not possible, at least one senior medical
student with previous collaborative audit experience should
be part of the data collection team.
2.3 A network of regional leads are useful to monitor local
progress and feedback to steering committee
2.4 Tracking regional variation in performance through the
study and targeting specific efforts to improve follow-up
and data completeness in these areas may increase data
quality and maximise efficiency.
2.5 In high-volume centres where achieving high data
completeness may be burdensome, consider permitting
involvement additional team members to provide support.
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